Dysfunction

LAS VEGAS — Among patients with gastroparesis, pyloric botulinum toxin may be effective among those with lesser pyloric impairments. However, those with worse pyloric dysfunction may not benefit, according to a presentation.

Cognitive impairment occurred relatively often within several months of patients having had COVID-19, according to results of a cross-sectional study published in JAMA Network Open.

Pulmonary dysfunction and septic shock were the most common causes of death in a cohort of patients hospitalized with COVID-19, according to a new study published in the Annals of the American Thoracic Society.